您的位置: 首页 > 2017年5月 第48卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

不同剂量麝香复方液静滴对老年人全麻术后早期轻度认知障碍发生的比较

Comparison of different doses of musk compound solution in the early stage of mild cognitive impairment in elderly patients after general anesthesia

来源期刊: 广州医药 | 34-38 发布时间:2021-12-01 收稿时间:2025/11/13 17:12:11 阅读量:15
作者:
关键词:
复方麝香注射液剂量老年全身麻醉轻度认知障碍
Compound musk injectionDoseElderlyGeneral anesthesiaMild cognitive impairment(MCI)
DOI:
10.3969/j.issn.1000-8535.2017.03.008
收稿时间:
2017-03-15 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 观察手术前静滴不同剂量复方麝香注射液对老年患者全麻术后早期轻度认知障碍(MCI)发生的影响。方法 选择下肢与下腹部手术全麻患者120例(ASA Ⅰ-Ⅱ级),将其随机分为4组,组Ⅰ(n=30,对照),采用质量浓度为9 g/L的生理盐水100 mL静脉滴注;组II(n=30):应用低剂量复方麝香注射液(0.1 mL/kg,加入质量浓度为9 g/L的生理盐水100 mL)手术开始前0.5 h静脉滴注,其速率为200 mL/h;组Ⅲ(n=30): 应用中剂量复方麝香注射液(0.2 mL/kg), 药物配伍、治疗时间和注射速度与组Ⅱ相同;组Ⅳ(n=30):高剂量复方麝香注射液(0.3 mL/kg),用药方法同组Ⅱ。各组术前用药、麻醉诱导、术中麻醉深度、麻醉苏醒等用药与方法相同;观察各组患者术前、术后第1天、3天、7天的CCSE、FAQ、MMSE评分等。结果 4组患者手术时间、麻醉时间、术中出血量、苏醒时间基本相同(P>0.05),4组手术后第1天、3天及7天CCSE、FAQ、MMSE认知功能评分均减少, 组Ⅱ、组Ⅲ、组Ⅳ下降的变化幅度较小,得分高于组Ⅰ(P<0.05),组Ⅱ、组Ⅲ、组Ⅳ组间比较差异无统计学意义(P﹥0.05);术后第1天、3天、7天MCI发生率,组Ⅰ分别为66.7%、33.3%和16.7%;组Ⅱ为50.0%、16.7%和6.7%;组Ⅲ为50.0%、16.7%和6.7%。组Ⅳ为46.7%、20.0%和10.0%,用药组比组Ⅰ降低(P<0.05),但组Ⅱ、组Ⅲ、组Ⅳ之间无明显差异(P﹥0.05);4组术后不良反应组间比较差异无统计学意义。结论 术前静脉滴注复方麝香注射液0.1 mL/kg可有效降低老年患者全麻术后MCI的发生,增加麝香注射液剂量(0.2 mL/kg、0.3 mL/kg)对于老年手术患者MCI未见增效作用,临床选用静滴的剂量0.1 mL/kg即可。
Objective To observe the effect of different doses of compound musk injection before operation on early mild cognitive impairment (MCI) in elderly patients after general anesthesia. Methods We selected 120 cases of lower limb and lower abdominal surgery general anesthesia (ASA level Ⅰ-Ⅱ),and divided them randomly into 4 groups: Group Ⅰ (n=30,control): 0.9% saline 100mL intravenous infusion; Group Ⅱ (n=30): low dose compound musk injection (0.1 mL/kg,add 0.9% saline 100 mL), 0.5h before the start of surgery, intravenous drip, the rate was 200 mL/h; Group Ⅲ (n=30): medium dose compound musk injection (0.2 mL/kg), the same as group Ⅱ in drug compatibility,treatment time and injection rate; Group Ⅳ (n=30): high dose compound musk injection (0.3 mL/kg), the same as group Ⅱ in drug compatibility, treatment time and injection rate. Each premedication, induction of anesthesia, anesthesia depth,intraoperative awake and anesthesia medication were the same. And we observed each group about preoperative and postoperative CCSE,FAQ and MMSE(mini-mental state examination) score of the 1st days,3rd days and 7th days. Results In the 4 groups of patients,the operation time,anesthesia time,intraoperative blood loss,recovery time were basically the same (P>0.05); CCSE,FAQ,MMSE cognitive function scores of 4 groups were reduced after operation on the first day,the third day and the seventh day; group Ⅱ,group Ⅲ,group Ⅳ decreased slightly.The scores were higher than group Ⅰ (P<0.05),and there were no significant differences between group Ⅱ,group Ⅲ and group Ⅳ (P>0.05); The incidence of MCI in first days, third day and seventh day after operation respectively was: group Ⅰ 66.7%,33.3% and 16.7%; group Ⅱ 50%,16.7% and 6.7%; group Ⅲ 50%,16.7% and 6.7%; group Ⅳ 46.7%,20% and 10%.Those of the drug groups were lower than group Ⅰ (P<0.05), but there was no significant difference between group Ⅱ, group Ⅲ and group Ⅳ (P>0.05).There were no significant differences in the 4 groups in postoperative adverse reactions. Conclusion Preoperative intravenous infusion of compound musk injection 0.1 ml/kg, may effectively reduce the incidence of MCI in elderly patients after general anesthesia. Increasing musk injection dose (0.2 ml/kg,0.3 ml/kg and 0.4 mg/kg) was no synergistic effect on MCI in elderly patients,0.1ml/kg is enough.
1、 胡敏, 熊乡情, 刘琨, 等. 腹腔镜阑尾切除术结合快速康复外科理念与传统方法疗效比较[J]. 广州医药, 2015, 46(1): 57-60. 胡敏, 熊乡情, 刘琨, 等. 腹腔镜阑尾切除术结合快速康复外科理念与传统方法疗效比较[J]. 广州医药, 2015, 46(1): 57-60.
2、 谢创波,屠伟峰.术后镇痛管理的现状与展望[J]. 现代医院, 2016, 16(12): 761-1763. 谢创波,屠伟峰.术后镇痛管理的现状与展望[J]. 现代医院, 2016, 16(12): 761-1763.
3、 何倩婷,龚艳霞.快速康复外科理念在手术室护理中的应用效果观察[J]. 广州医药, 2015, 46(6): 389-391. 何倩婷,龚艳霞.快速康复外科理念在手术室护理中的应用效果观察[J]. 广州医药, 2015, 46(6): 389-391.
4、 黄文起,黄宇光. 多学科合力促进ERAS的发展[J]. 广东医学, 2016, 36(18): 2689-2691. 黄文起,黄宇光. 多学科合力促进ERAS的发展[J]. 广东医学, 2016, 36(18): 2689-2691.
5、 中国医师协会麻醉学医师分会.促进术后康复的麻醉管理专家共识[J]. 中华麻醉学杂志,2015, 35(2):141-148 . 中国医师协会麻醉学医师分会.促进术后康复的麻醉管理专家共识[J]. 中华麻醉学杂志,2015, 35(2):141-148 .
6、 FIDALGO A R. Experimental insights into age-exacerbated cognitive dysfunction after peripheral surgery[J]. AgingCell, 2013,12(3):523-524. FIDALGO A R. Experimental insights into age-exacerbated cognitive dysfunction after peripheral surgery[J]. AgingCell, 2013,12(3):523-524.
7、 PARNOWSKI T, KA?UZA B. Metabolic syndrome and cognitive dysfunction in the old age[J]. Psychiatr Pol, 2013, 47(6):1087-1099. PARNOWSKI T, KA?UZA B. Metabolic syndrome and cognitive dysfunction in the old age[J]. Psychiatr Pol, 2013, 47(6):1087-1099.
8、 KAPHINGST K A, GOODMAN M S, MACMILLAN W D,et al. Effect of cognitive dysfunction on the relationship between age and health literacy[J]. Patient Educ Couns, 2014, 95(2):218-225. KAPHINGST K A, GOODMAN M S, MACMILLAN W D,et al. Effect of cognitive dysfunction on the relationship between age and health literacy[J]. Patient Educ Couns, 2014, 95(2):218-225.
9、 KOTEKAR N, KURUVILLA C S, MURTHY V. Post-operative dysfunction in the elderly: a prospective clinical study[J]. Indian Anaesth, 2014, 58(3): 263-268. KOTEKAR N, KURUVILLA C S, MURTHY V. Post-operative dysfunction in the elderly: a prospective clinical study[J]. Indian Anaesth, 2014, 58(3): 263-268.
10、 SILVERSTEIN J H,TIMBERGER M,REICH D L,et al. Central nervous systerm dysfunction after noneardiac surgery and anethesia in the elderly[J]. Anesthesiologists, 2007, 106(3): 622-628. SILVERSTEIN J H,TIMBERGER M,REICH D L,et al. Central nervous systerm dysfunction after noneardiac surgery and anethesia in the elderly[J]. Anesthesiologists, 2007, 106(3): 622-628.
11、 MONK T G,WELDON B C,GARVAN C W,et al. Predictors of cognitive dysfunction after major noneardiac surgery[J]. Anesthesiology,2008,108(1): 18-30. MONK T G,WELDON B C,GARVAN C W,et al. Predictors of cognitive dysfunction after major noneardiac surgery[J]. Anesthesiology,2008,108(1): 18-30.
12、 刘进,邓小明.临床麻醉监测指南[M]. 北京:人民卫生出版社,2014:11-15. 刘进,邓小明.临床麻醉监测指南[M]. 北京:人民卫生出版社,2014:11-15.
13、 叶太财,周良军,曹强,等.复方麝香注射液对老年患者全麻术后早期认知功能障碍的影响[J]. 广东医学,2016,37(18)2714-2717. 叶太财,周良军,曹强,等.复方麝香注射液对老年患者全麻术后早期认知功能障碍的影响[J]. 广东医学,2016,37(18)2714-2717.
14、 赵昭, 王显春,刘志恒,等.川芎嗪对老年患者全髋手术后血清S100β蛋白及早期认知功能障碍的影响[J]. 广东医学,2015,36(2):294-296. 赵昭, 王显春,刘志恒,等.川芎嗪对老年患者全髋手术后血清S100β蛋白及早期认知功能障碍的影响[J]. 广东医学,2015,36(2):294-296.
15、 尹光明, 姚尚龙, 梁卫东. 老年患者术后认知功能障碍与血清S100β及神经元特异性烯醇化酶的关系[J]. 中华行为医学与脑科学杂志, 2010, 19(1): 42-43. 尹光明, 姚尚龙, 梁卫东. 老年患者术后认知功能障碍与血清S100β及神经元特异性烯醇化酶的关系[J]. 中华行为医学与脑科学杂志, 2010, 19(1): 42-43.
16、 HANNING C D. Postoperative cognitive dysfunction[J]. Br J Anaesth, 2005, 95(1): 82-87. HANNING C D. Postoperative cognitive dysfunction[J]. Br J Anaesth, 2005, 95(1): 82-87.
17、 BIEDLER A,JUCKENHOFEL S,LARSEN R,et al. Postoperative cognition disorders in elderly patients.The results of the “international study of postoperative cognitive dysfunction” ISPOCD 1[J]. Anaesthesist, 1999,48(12): 884-895. BIEDLER A,JUCKENHOFEL S,LARSEN R,et al. Postoperative cognition disorders in elderly patients.The results of the “international study of postoperative cognitive dysfunction” ISPOCD 1[J]. Anaesthesist, 1999,48(12): 884-895.
18、 PETERSEN R C, NEGASH S. Mild cognitive impairment: an overview[J]. CNS Spectr, 2008, 13(1): 45-53. PETERSEN R C, NEGASH S. Mild cognitive impairment: an overview[J]. CNS Spectr, 2008, 13(1): 45-53.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录